Medtronic Aktie
| 92,20USD | 2,13USD | 2,36% |
WKN DE: A14M2J / ISIN: IE00BTN1Y115
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 90 000 | 95 000 | 95 000 | 95 000 | 95 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,33 | 0,33 | 0,33 | 0,34 | 0,35 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 22 548 | 23 059 | 21 675 | 21 935 | 23 814 |
| Summe Anlagevermögen | 70 535 | 67 922 | 69 273 | 68 046 | 67 866 |
| Summe Aktiva | 93 083 | 90 981 | 90 948 | 89 981 | 91 680 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 41 481 | 38 260 | 39 283 | 39 561 | 43 424 |
| Summe Eigenkapital | 51 602 | 52 722 | 51 665 | 50 420 | 48 256 |
| Summe Passiva | 93 083 | 90 982 | 90 948 | 89 981 | 91 680 |
Adresse
| Parkmore Business Park West, 2 Galway | |
| Telefon | +353 (1) 438-1700 |
| Internet | http://www.medtronic.com |
Management
|
Adam S. Arthur
Chief Medical Officer |
|
Bob Hopkins
Senior Vice President & Head-Global Strategy |
|
Craig Arnold
Lead Independent Director |
|
Denise L. Blomquist
Chief Accounting Officer, VP & Controller |
|
Elizabeth G. Nabel
Independent Director |
|
Geoffrey Straub Martha
Chairman & Chief Executive Officer |
|
Gregory L. Smith
Executive Vice President-Enterprise Operations |
|
Gregory P. Lewis
Independent Director |
|
Harry Kiil
President-Cardiovascular Portfolio & Executive VP |
|
John P. Groetelaars
Independent Director |
|
Joon Sup Lee
Independent Director |
|
Kelly Wei
Vice President-Corporate Strategy |
|
Kendall J. Powell
Independent Director |
|
Kenneth E. Washington
Chief Technology & Innovation Officer, SVP |
|
Kevin E. Lofton
Independent Director |
|
Laura Mauri
Director-Scientific, Clinical & Regulatory Officer |
|
Lidia L. Fonseca
Independent Director |
|
Matthew Walter
Chief Human Resources Officer & Senior VP |
|
Michelle Quinn
Secretary, Executive VP & General Counsel |
|
Que Thanh Dallara
EVP & President-Global Diabetes Operating Unit |
|
Raman Venkatesh
Chief Sustainability Officer & Vice President |
|
Randall J. Hogan
Independent Director |
|
Rashmi Kumar
Chief Information Officer & Senior Vice President |
|
Ryan Weispfenning
Vice President & Head-Investor Relations |
|
Sally Saba
Chief Inclusion & Diversity Officer |
|
Scott C. Donnelly
Independent Director |
|
Scott Cundy
Chief Quality Officer & Senior Vice President |
|
Thierry Pieton
Chief Financial Officer & Executive Vice President |
|
William R. Jellison
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.